Structure-activity relationship of a novel pentapeptide with cancer cell growth-inhibitory activity

Masakatsu Kamiya, Keisuke Oyauchi, Yoshinori Sato, Takuya Yokoyama, Mofei Wang, Tomoyasu Aizawa, Yasuhiro Kumaki, Mineyuki Mizuguchi, Kunio Imai, Makoto Demura, Koichi Suzuki, Keiichi Kawano*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

We previously reported that yamamarin, a pentapeptide with an amidated C-terminus (DILRG-NH2) isolated from larvae of the silkmoth, and its palmitoylated analog (C16-DILRG-NH2) suppressed proliferation of rat hepatoma (liver cancer) cells. In this study, we investigated the structure-activity relationship of yamamarin by in vitro assay and spectroscopic methods (CD and NMR) for various analogs. The in vitro assay results demonstrated that the chemical structure of the C-terminal part (-RG-NH 2) of yamamarin is essential for its activity. The CD and NMR results indicated that yamamarin and its analog adopt predominantly a random coil conformation. Moreover, a comparison of NMR spectra of DILRG-NH2 and C16-DILRG-NH2 revealed that the N-terminal palmitoyl group of C16-DILRG-NH2 did not affect the conformation of the C-terminal part, which is essential for activity. Together, these results should assist in the design of more sophisticated anticancer drugs.

Original languageEnglish
Pages (from-to)242-248
Number of pages7
JournalJournal of Peptide Science
Volume16
Issue number5
DOIs
StatePublished - 2010/05

Keywords

  • CD
  • Cell growth suppression
  • Insect pentapeptide
  • NMR

ASJC Scopus subject areas

  • Structural Biology
  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Structure-activity relationship of a novel pentapeptide with cancer cell growth-inhibitory activity'. Together they form a unique fingerprint.

Cite this